Skip to content

Clinical trials

Phase 3 Respiratory Distress Syndrome trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Phase 3 Country / region: France Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20102
20111
20121
20131
20151
20161
20171
20191
20207
20211
20223
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10
Unknown status6
Completed4
Recruiting3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris2
Centre Hospitalier St Anne2
Centre Hospitalier Universitaire de Besancon2
University Hospital, Clermont-Ferrand2
University Hospital, Strasbourg, France2
Alexion Pharmaceuticals, Inc.1
AstraZeneca1
Biotest1
Centre Chirurgical Marie Lannelongue1
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome25
COVID-199
Acute Lung Injury3
Coronavirus Infections3
Influenza, Human3
Pneumonia3
Pneumonia, Viral3
Severe Acute Respiratory Syndrome3
Acute Kidney Injury2
Respiratory Tract Infections2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.